News Corporate Actions Emcure Pharmaceuticals Allots 17,000 Equity Shares Under Employee Stock Option SchemeEmcure Pharmaceuticals Allots 17,000 Equity Shares Under Employee Stock Option Scheme
Emcure Pharmaceuticals has allotted 17,000 equity shares to employees under its ESOS 2013 scheme following committee approval on March 03, 2026. The allotment increased the company's paid-up share capital from Rs. 1,89,57,25,470 to Rs. 1,89,58,95,470, with total equity shares rising to 18,95,89,547. The newly issued shares carry equal rights with existing equity shares and comply with SEBI listing regulations.
*this image is generated using AI for illustrative purposes only.
Emcure Pharmaceuticals has completed the allotment of 17,000 equity shares to eligible employees under its Employee Stock Option Scheme 2013 (Emcure ESOS 2013). The allotment was approved through a Resolution by Circulation by the company's Nomination and Remuneration Committee on March 03, 2026.
ESOP Allotment Details
The allotment follows the exercise of 17,000 vested stock options by eligible employees under the Emcure ESOS 2013 scheme. Each equity share carries a face value of Rs. 10 and the newly issued shares will enjoy equal rights with existing equity shares of the company.
| Parameter: | Details |
|---|---|
| Shares Allotted: | 17,000 equity shares |
| Face Value: | Rs. 10 per share |
| Scheme: | Emcure ESOS 2013 |
| Approval Date: | March 03, 2026 |
| Approving Authority: | Nomination and Remuneration Committee |
Impact on Share Capital
The allotment has resulted in an increase in the company's issued and paid-up share capital. The capital structure has been revised following the incorporation of the newly allotted shares.
| Capital Component: | Before Allotment | After Allotment |
|---|---|---|
| Number of Shares: | 18,95,72,547 | 18,95,89,547 |
| Face Value per Share: | Rs. 10 | Rs. 10 |
| Total Paid-up Capital: | Rs. 1,89,57,25,470 | Rs. 1,89,58,95,470 |
Regulatory Compliance
The allotment was conducted in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has informed both the National Stock Exchange of India Limited and BSE Limited about this corporate action as required under the regulatory framework.
The newly allotted equity shares will rank pari passu in all aspects with the existing equity shares of Emcure Pharmaceuticals, ensuring equal treatment for all shareholders. This ESOP exercise demonstrates the company's commitment to employee participation in its growth and value creation.
Historical Stock Returns for Emcure Pharmaceuticals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.70% | +0.51% | -2.65% | -1.59% | +47.99% | +6.34% |
18
